Published in Surgery Litigation and Law Weekly, September 1st, 2006
The cancer, called post-transplant lymphoproliferative disorder (PTLD), is caused by Epstein-Barr virus (EBV), a herpes virus that infects more than 90% of Americans but is ordinarily kept under control by the immune system. That control can be lost in people whose immune system is suppressed to prevent rejection of a transplanted organ. The cancer arises only in some transplant patients, but doctors don't know why.
Study findings are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.